JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keffel, S.
Right arrow Articles by Michel, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keffel, S.
Right arrow Articles by Michel, M. C.

Vol. 291, Issue 3, 1172-1178, December 1999

Neuropeptide-Y Stimulation of Extracellular Signal-Regulated Kinases in Human Erythroleukemia Cells1

Susanne Keffel, Martina Schmidt, Angela Bischoff and Martin C. Michel

Departments of Medicine (S.K., A.B., M.C.M.) and Pharmacology (M.S.), University of Essen, Essen, Germany

We have used human erythroleukemia (HEL) cells to investigate distal signaling mechanisms of neuropeptide-Y (NPY) receptors. NPY did not activate phospholipase D, determined as a phosphatidylethanol formation, or protein kinase C (PKC) determined enzymatically as a translocation to the plasma membrane. However, NPY caused a rapid (already maximal after 30 s) and concentration-dependent (maximum at 10-100 nM) activation of extracellular signal-regulated kinase (ERK) as assessed by immunoblotting with epitope-specific, antiphosphotyrosine antibodies and in some cases enzymatically. ERK activation by 100 nM NPY was abolished by the Y1 NPY receptor antagonist BIBP 3226 (1 µM), pertussis toxin treatment (100 ng ml-1 overnight), the mitogen-activated protein kinase (MAPK) kinase inhibitor PD 98059 (100 µM), and the phosphatidylinositol-3-kinase inhibitor wortmannin (100 nM). Whereas the PKC inhibitor staurosporine (3 µM) inhibited ERK activation by NPY, the chemically distinct PKC inhibitors calphostin C (3 µM), Gö 6976 (3 µM), and bisindolylmaleimide I (3 µM) did not. NPY did not activate other MAPK such as jun N-terminal kinase or p38 MAPK. We conclude that NPY does not activate phospholipase D, PKC, jun N-terminal kinase, or p38 MAPK in HEL cells. However, NPY activates ERK by a pathway involving Y1 receptors, pertussis toxin-sensitive G proteins, and phosphatidylinositol-3-kinase, whereas PKC may not be involved. Staurosporine may have PKC-independent effects on ERK activation.

0022-3565/99/2913-1172$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 FASEB J.Home page
K. Yang, H. Guan, E. Arany, D. J. Hill, and X. Cao
Neuropeptide Y is produced in visceral adipose tissue and promotes proliferation of adipocyte precursor cells via the Y1 receptor
FASEB J, July 1, 2008; 22(7): 2452 - 2464.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Ruscica, E. Dozio, S. Boghossian, G. Bovo, V. Martos Riano, M. Motta, and P. Magni
Activation of the Y1 Receptor by Neuropeptide Y Regulates the Growth of Prostate Cancer Cells
Endocrinology, March 1, 2006; 147(3): 1466 - 1473.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Thiriet, X. Deng, M. Solinas, B. Ladenheim, W. Curtis, S. R. Goldberg, R. D. Palmiter, and J. L. Cadet
Neuropeptide Y Protects against Methamphetamine-Induced Neuronal Apoptosis in the Mouse Striatum
J. Neurosci., June 1, 2005; 25(22): 5273 - 5279.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
L. Galas, M.-C. Tonon, D. Beaujean, R. Fredriksson, D. Larhammar, I. Lihrmann, S. Jegou, A. Fournier, N. Chartrel, and H. Vaudry
Neuropeptide Y Inhibits Spontaneous {alpha}-Melanocyte-Stimulating Hormone ({alpha}-MSH) Release via a Y5 Receptor and Suppresses Thyrotropin-Releasing Hormone-Induced {alpha}-MSH Secretion via a Y1 Receptor in Frog Melanotrope Cells
Endocrinology, May 1, 2002; 143(5): 1686 - 1694.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H. Wu, H.-W. Shen, T.-F. Wu, L. F. Brass, and K.-C. Sung
Extracellular Signal-Regulated Kinases and G Protein-Coupled Receptors in Megakaryocytic Human Erythroleukemia Cells: Selective Activation, Differential Regulation, and Dissociation from Mitogenesis
J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 339 - 345.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.